Evaluation of the Effect of Recombinant Human Angiogenin on the Functional Properties of EA.Hy926 Endothelial Cells and Human Skin Fibroblasts In Vitro.

IF 0.9 4区医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Bulletin of Experimental Biology and Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-13 DOI:10.1007/s10517-025-06338-6

A P Lykov, A M Goryachkin, M A Surovtseva, M N Drovosekov, O V Poveshchenko

{"title":"Evaluation of the Effect of Recombinant Human Angiogenin on the Functional Properties of EA.Hy926 Endothelial Cells and Human Skin Fibroblasts In Vitro.","authors":"A P Lykov, A M Goryachkin, M A Surovtseva, M N Drovosekov, O V Poveshchenko","doi":"10.1007/s10517-025-06338-6","DOIUrl":null,"url":null,"abstract":"<p><p>We studied the effects of recombinant human angiogenin on in vitro proliferation, migration, apoptosis, and secretion of human skin fibroblasts (FB) and endothelial cells (EC; EA.Hy926). The most potent stimulation of migration and proliferation of EC and FB was observed at angiogenin concentration of 125 ng/ml in a serum-free medium. Angiogenin had little effect on apoptosis/necrosis of EC and FB. It promoted IL-1β production by EC in a serum-free medium and did not affect FB. Angiogenin had the opposite effects on the production of TNFα and IL-10 by cells: it suppressed the production of these factors by EC in a serum-free medium and enhanced their production by FB in media with and without serum. In a serum-free medium, VEGF production by EC increased and by FB drops. NO production by EC in response to angiogenin stimulation did not depend on the culturing conditions, while NO production by FB increased in complete culture media. Thus, the presence of FCS in the culture medium considerably modulated the effect of angiogenin.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"367-370"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06338-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

We studied the effects of recombinant human angiogenin on in vitro proliferation, migration, apoptosis, and secretion of human skin fibroblasts (FB) and endothelial cells (EC; EA.Hy926). The most potent stimulation of migration and proliferation of EC and FB was observed at angiogenin concentration of 125 ng/ml in a serum-free medium. Angiogenin had little effect on apoptosis/necrosis of EC and FB. It promoted IL-1β production by EC in a serum-free medium and did not affect FB. Angiogenin had the opposite effects on the production of TNFα and IL-10 by cells: it suppressed the production of these factors by EC in a serum-free medium and enhanced their production by FB in media with and without serum. In a serum-free medium, VEGF production by EC increased and by FB drops. NO production by EC in response to angiogenin stimulation did not depend on the culturing conditions, while NO production by FB increased in complete culture media. Thus, the presence of FCS in the culture medium considerably modulated the effect of angiogenin.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Bulletin of Experimental Biology and Medicine 医学-医学：研究与实验

CiteScore

1.50

自引率

14.30%

发文量

265

审稿时长

2 months

期刊介绍： Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005. World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells. The Russian Volume Year is published in English from April.